Archontakis-Barakakis Paraschos, Mavridis Theodoros, Chlorogiannis David-Dimitris, Barakakis Georgios, Laou Eleni, Sessler Daniel I, Gkiokas George, Chalkias Athanasios
Department of Medicine, Redington-Fairview General Hospital, Skowhegan, Maine, USA.
Department of Neurology, Tallaght University Hospital (TUH)/The Adelaide and Meath Hospital incorporating the National Children's Hospital (AMNCH), Dublin, Ireland.
Clin Transl Med. 2025 Jan;15(1):e70136. doi: 10.1002/ctm2.70136.
The gastrointestinal tract can be deranged by ailments including sepsis, trauma and haemorrhage. Ischaemic injury provokes a common constellation of microscopic and macroscopic changes that, together with the paradoxical exacerbation of cellular dysfunction and death following restoration of blood flow, are collectively known as ischaemia-reperfusion injury (IRI). Although much of the gastrointestinal tract is normally hypoxemic, intestinal IRI results when there is inadequate oxygen availability due to poor supply (pathological hypoxia) or abnormal tissue oxygen use and metabolism (dysoxia). Intestinal oxygen uptake usually remains constant over a wide range of blood flows and pressures, with cellular function being substantively compromised when ischaemia leads to a >50% decline in intestinal oxygen consumption. Restoration of perfusion and oxygenation provokes additional injury, resulting in mucosal damage and disruption of intestinal barrier function. The primary cellular mechanism for sensing hypoxia and for activating a cascade of cellular responses to mitigate the injury is a family of heterodimer proteins called hypoxia-inducible factors (HIFs). The HIF system is connected to numerous biochemical and immunologic pathways induced by IRI and the concentration of those proteins increases during hypoxia and dysoxia. Activation of the HIF system leads to augmented transcription of specific genes in various types of affected cells, but may also augment apoptotic and inflammatory processes, thus aggravating gut injury. KEY POINTS: During intestinal ischaemia, mitochondrial oxygen uptake is reduced when cellular oxygen partial pressure decreases to below the threshold required to maintain normal oxidative metabolism. Upon reperfusion, intestinal hypoxia may persist because microcirculatory flow remains impaired and/or because available oxygen is consumed by enzymes, intestinal cells and neutrophils.
胃肠道会因败血症、创伤和出血等疾病而紊乱。缺血性损伤会引发一系列常见的微观和宏观变化,再加上血流恢复后细胞功能障碍和死亡的反常加剧,这些变化统称为缺血再灌注损伤(IRI)。尽管胃肠道的大部分区域通常处于低氧状态,但当由于供应不足(病理性缺氧)或异常的组织氧利用和代谢(氧利用障碍)导致氧供应不足时,就会发生肠道IRI。在广泛的血流和压力范围内,肠道氧摄取通常保持恒定,当缺血导致肠道氧消耗下降>50%时,细胞功能会受到实质性损害。灌注和氧合的恢复会引发额外的损伤,导致粘膜损伤和肠屏障功能破坏。感知缺氧并激活一系列细胞反应以减轻损伤的主要细胞机制是一类称为缺氧诱导因子(HIFs)的异二聚体蛋白家族。HIF系统与IRI诱导的众多生化和免疫途径相关,并且这些蛋白的浓度在缺氧和氧利用障碍期间会增加。HIF系统的激活会导致各种受影响细胞中特定基因的转录增加,但也可能会增强凋亡和炎症过程,从而加重肠道损伤。要点:在肠道缺血期间,当细胞氧分压降至维持正常氧化代谢所需的阈值以下时,线粒体氧摄取会减少。再灌注时,肠道缺氧可能会持续存在,因为微循环血流仍然受损和/或因为可用氧被酶、肠道细胞和中性粒细胞消耗。